Morning Movers - StereotaxisInc, Veeco Instruments Inc, ACADIA Pharmaceuticals Inc, Array BiopharmaInc continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

New York, NY -- (SBWIRE) -- 03/25/2013 -- issues special report on the Morning Movers – StereotaxisInc (NASDAQ:STXS), Veeco Instruments Inc. (NASDAQ:VECO), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Array BiopharmaInc (NASDAQ:ARRY)

StereotaxisInc (NASDAQ:STXS) shares skyrocketed +54.19% to $52.51% in the mid-day trading and its total traded volume was 1.10 million shares. Stock price 52 weeks high was $7.20 and its 52 weeks low price was $1.01.

StereotaxisInc (NASDAQ:STXS) has received regulatory authorization of its Niobe(R) remote magnetic technology for cardiac ablations in Japan, a perilous milestone in acquiring full market entry into the country. This approval permits the Company to initiate marketing efforts, including founding a local business structure with in-country suppliers, although working on gaining compensation sanction for full market entry, or the aptitude to start sales.

What was the Moving Force behind STXS On Bullish Run? Read This Research Report on STXS

Veeco Instruments Inc. (NASDAQ:VECO) surged +11.48% to $38.97 in the mid-day with the total traded volume of 2.21 million shares. Its fifty two week range was $26.15-$40.34. The total market capitalization remained $1.53 billion.

VECO is ahead its 52 week low with 48.34% and its last month price volatility remained 2.58%. Its beta coefficient was 2.43 with a target price of $29.63. In its share capital VECO has 39.16million outstanding shares while 38.74million shares have been floated in market. VECO has insider ownership of 0.09% with its institutional ownership remained 62.58%. Company’s past five year EPS growth rate was +57.32%.

For How Long VECO will Fight for Profitability? Read This Trend Analysis report

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported the gain of +10.96% to $8.40 in the mid-day trading session with the total traded volume of 4.10 million shares more than the average volume of 2.11 million shares. ACAD has outstanding shares of 78.76 million with the total market cap of 659.21 million. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.

For How Long ACAD’s Gloss will Attract Investors? Find out via this report

Array BiopharmaInc (NASDAQ:ARRY) moved up +8.86% to $4.67 in the mid-day trading hours and its total traded volume was 1.33 million shares. Stock price 52 weeks high was $6.17 and 52 weeks low price was $3.00. ARRY has market cap of 544.81 million. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

Will ARRY Continue To Move Higher? Find Out Here

About is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.

Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!

This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.

Read Our Full Disclaimer at:

For more information on this press release visit:

Media Relations Contact

Bobby Delp
Email: Click to Email Bobby Delp

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here